ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 113 filers reported holding ARRAY BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,035,078,000 | +153.8% | 65,510 | +33.6% | 0.01% | +100.0% |
| Q1 2019 | $1,195,888,000 | +395.6% | 49,052 | +189.6% | 0.00% | +200.0% |
| Q4 2018 | $241,324,000 | -31.3% | 16,935 | -26.7% | 0.00% | 0.0% |
| Q3 2018 | $351,257,000 | +0.8% | 23,109 | +11.3% | 0.00% | 0.0% |
| Q2 2018 | $348,302,000 | -88.6% | 20,757 | -88.9% | 0.00% | -83.3% |
| Q1 2018 | $3,049,017,000 | +483.1% | 186,827 | +357.3% | 0.01% | +500.0% |
| Q4 2017 | $522,893,000 | +126.0% | 40,851 | +117.1% | 0.00% | 0.0% |
| Q3 2017 | $231,400,000 | +39.4% | 18,813 | -5.1% | 0.00% | 0.0% |
| Q2 2017 | $165,944,000 | +739.2% | 19,826 | +796.3% | 0.00% | – |
| Q1 2017 | $19,775,000 | -25.2% | 2,212 | -26.5% | 0.00% | – |
| Q4 2016 | $26,449,000 | -61.2% | 3,009 | -70.2% | 0.00% | – |
| Q3 2016 | $68,094,000 | +240.2% | 10,088 | +79.4% | 0.00% | – |
| Q2 2016 | $20,014,000 | -85.4% | 5,622 | -82.7% | 0.00% | – |
| Q4 2015 | $136,864,000 | +2.9% | 32,432 | +11.2% | 0.00% | – |
| Q3 2015 | $132,992,000 | +57.2% | 29,165 | +148.5% | 0.00% | – |
| Q2 2015 | $84,609,000 | +246.6% | 11,735 | +254.3% | 0.00% | – |
| Q1 2015 | $24,409,000 | -8.4% | 3,312 | -55.6% | 0.00% | – |
| Q3 2014 | $26,639,000 | +251.0% | 7,462 | +392.5% | 0.00% | – |
| Q4 2013 | $7,590,000 | -96.2% | 1,515 | -95.2% | 0.00% | – |
| Q3 2013 | $197,939,000 | +4.2% | 31,823 | -24.0% | 0.00% | – |
| Q2 2013 | $190,017,000 | – | 41,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|